Zentalis Pharmaceuticals, Inc. (ZNTL) Q1 2025 Earnings
ZNTL·Reported May 14, 2025·Before market open
Diluted EPS came in at $-0.67.
Diluted EPS
$-0.67met estimate
Consensus: $-0.67
Financial Snapshot
Trailing eight quarters through Q1 2025
Q1 2025 Earnings FAQ
Common questions about Zentalis Pharmaceuticals, Inc.'s Q1 2025 earnings report.
Zentalis Pharmaceuticals, Inc. (ZNTL) reported Q1 2025 earnings on May 14, 2025 before market open.
Zentalis Pharmaceuticals, Inc. reported diluted EPS of $-0.67 for Q1 2025.
EPS beat the consensus estimate of $-0.67 by $0.00.
You can read the 10-Q periodic report (0001725160-25-000105) directly on SEC EDGAR. The filing index links above go to sec.gov.